Literature DB >> 21937950

Cecal ligation and puncture followed by methicillin-resistant Staphylococcus aureus pneumonia increases mortality in mice and blunts production of local and systemic cytokines.

Enjae Jung1, Erin E Perrone, Zhe Liang, Elise R Breed, Jessica A Dominguez, Andrew T Clark, Amy C Fox, W Michael Dunne, Eileen M Burd, Alton B Farris, Richard S Hotchkiss, Craig M Coopersmith.   

Abstract

Mortality in the intensive care unit frequently results from the synergistic effect of two temporally distinct infections. This study examined the pathophysiology of a new model of intra-abdominal sepsis followed by methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. Mice underwent cecal ligation and puncture (CLP) or sham laparotomy followed 3 days later by an intratracheal injection of MRSA or saline. Both CLP/saline and sham/MRSA mice had 100% survival, whereas animals with CLP followed by MRSA pneumonia had 67% 7-day survival. Animals subjected to CLP/MRSA had increased bronchoalveolar lavage concentrations of MRSA compared with sham/MRSA animals. Animals subjected to sham/MRSA pneumonia had increased bronchoalveolar lavage levels of interleukin 6 (IL-6), tumor necrosis factor α, and granulocyte colony-stimulating factor compared with those given intratracheal saline, whereas CLP/MRSA mice had a blunted local inflammatory response with markedly decreased cytokine levels. Similarly, animals subjected to CLP/saline had increased peritoneal lavage levels of IL-6 and IL-1β compared with those subjected to sham laparotomy, whereas this response was blunted in CLP/MRSA mice. Systemic cytokines were upregulated in both CLP/saline and sham/MRSA mice, and this was blunted by the combination of CLP/MRSA. In contrast, no synergistic effect on pneumonia severity, white blood cell count, or lymphocyte apoptosis was identified in CLP/MRSA mice compared with animals with either insult in isolation. These results indicate that a clinically relevant model of CLP followed by MRSA pneumonia causes higher mortality than could have been predicted from studying either infection in isolation, and this was associated with a blunted local (pulmonary and peritoneal) and systemic inflammatory response and decreased ability to clear infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21937950      PMCID: PMC3241900          DOI: 10.1097/SHK.0b013e3182360faf

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  36 in total

1.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

2.  Selective defects of T lymphocyte function in patients with lethal intraabdominal infection.

Authors:  C D Heidecke; T Hensler; H Weighardt; N Zantl; H Wagner; J R Siewert; B Holzmann
Journal:  Am J Surg       Date:  1999-10       Impact factor: 2.565

Review 3.  Evolving concepts in the pathogenesis of postinjury multiple organ failure.

Authors:  F A Moore; E E Moore
Journal:  Surg Clin North Am       Date:  1995-04       Impact factor: 2.741

4.  The epidemiology of sepsis in the United States from 1979 through 2000.

Authors:  Greg S Martin; David M Mannino; Stephanie Eaton; Marc Moss
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

5.  Diminished bacterial clearance is associated with decreased IL-12 and interferon-gamma production but a sustained proinflammatory response in a murine model of postseptic immunosuppression.

Authors:  E D Murphey; Cheng Y Lin; Roy W McGuire; Tracy Toliver-Kinsky; David N Herndon; Edward R Sherwood
Journal:  Shock       Date:  2004-05       Impact factor: 3.454

6.  Interaction between the innate and adaptive immune systems is required to survive sepsis and control inflammation after injury.

Authors:  Odhran Shelley; Thomas Murphy; Hugh Paterson; John A Mannick; James A Lederer
Journal:  Shock       Date:  2003-08       Impact factor: 3.454

7.  Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model.

Authors:  C C Baker; I H Chaudry; H O Gaines; A E Baue
Journal:  Surgery       Date:  1983-08       Impact factor: 3.982

8.  IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense.

Authors:  M L Steinhauser; C M Hogaboam; S L Kunkel; N W Lukacs; R M Strieter; T J Standiford
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

9.  Burn injury and pulmonary sepsis: development of a clinically relevant model.

Authors:  Kimberly A Davis; John M Santaniello; Li-Ke He; Kuzhali Muthu; Soman Sen; Stephen B Jones; Richard L Gamelli; Ravi Shankar
Journal:  J Trauma       Date:  2004-02

10.  Outcome following femur fracture and subsequent cecal ligation and puncture in endotoxin-sensitive (C3H/HeN) and endotoxin-resistant (C3H/HeJ) mice.

Authors:  C C Baker; T Niven-Fairchild; C Caragnano; T S Kupper
Journal:  J Surg Res       Date:  1991-02       Impact factor: 2.192

View more
  14 in total

1.  Mechanisms of methicillin-resistant Staphylococcus aureus pneumonia-induced intestinal epithelial apoptosis.

Authors:  Erin E Perrone; Enjae Jung; Elise Breed; Jessica A Dominguez; Zhe Liang; Andrew T Clark; W Michael Dunne; Eileen M Burd; Craig M Coopersmith
Journal:  Shock       Date:  2012-07       Impact factor: 3.454

2.  Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model.

Authors:  Yongqing Li; Ting Zhao; Baoling Liu; Ihab Halaweish; Ralph Mazitschek; Xiuzhen Duan; Hasan B Alam
Journal:  J Trauma Acute Care Surg       Date:  2015-02       Impact factor: 3.313

3.  Lactobacillus rhamnosus L34 Attenuates Gut Translocation-Induced Bacterial Sepsis in Murine Models of Leaky Gut.

Authors:  Wimonrat Panpetch; Wiwat Chancharoenthana; Kanthika Bootdee; Sumanee Nilgate; Malcolm Finkelman; Somying Tumwasorn; Asada Leelahavanichkul
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

Review 4.  Can the Cecal Ligation and Puncture Model Be Repurposed To Better Inform Therapy in Human Sepsis?

Authors:  John C Alverdy; Robert Keskey; Renee Thewissen
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

5.  Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis.

Authors:  Marcin F Osuchowski; Florin Craciun; Katrin M Weixelbaumer; Elizabeth R Duffy; Daniel G Remick
Journal:  J Immunol       Date:  2012-09-24       Impact factor: 5.422

6.  Post-sepsis immunosuppression depends on NKT cell regulation of mTOR/IFN-γ in NK cells.

Authors:  Edy Y Kim; Hadas Ner-Gaon; Jack Varon; Aidan M Cullen; Jingyu Guo; Jiyoung Choi; Diana Barragan-Bradford; Angelica Higuera; Mayra Pinilla-Vera; Samuel Ap Short; Antonio Arciniegas-Rubio; Tomoyoshi Tamura; David E Leaf; Rebecca M Baron; Tal Shay; Michael B Brenner
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

7.  Activation of Hepatic STAT3 Maintains Pulmonary Defense during Endotoxemia.

Authors:  Kristie L Hilliard; Eri Allen; Katrina E Traber; Yuri Kim; Gregory A Wasserman; Matthew R Jones; Joseph P Mizgerd; Lee J Quinton
Journal:  Infect Immun       Date:  2015-07-27       Impact factor: 3.441

8.  Polymicrobial sepsis alters antigen-dependent and -independent memory CD8 T cell functions.

Authors:  Sean Duong; Stephanie A Condotta; Deepa Rai; Matthew D Martin; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2014-03-19       Impact factor: 5.422

9.  Efficacy of two novel 2,2'-bifurans to inhibit methicillin-resistant Staphylococcus aureus infection in male mice in comparison to vancomycin.

Authors:  Wael M El-Sayed; Warda A Hussin; Mohamed A Ismail
Journal:  Drug Des Devel Ther       Date:  2012-10-12       Impact factor: 4.162

Review 10.  Inflammatory mediators in intra-abdominal sepsis or injury - a scoping review.

Authors:  Zhengwen Xiao; Crystal Wilson; Helen Lee Robertson; Derek J Roberts; Chad G Ball; Craig N Jenne; Andrew W Kirkpatrick
Journal:  Crit Care       Date:  2015-10-27       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.